Cancer biotherapy is a form of treatment that uses the natural immune system to protect the body against cancer.
This report aims to provide a comprehensive presentation of the global market for Cancer Biotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biotherapy. This report contains market size and forecasts of Cancer Biotherapy in global, including the following market information:
Global Cancer Biotherapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Biotherapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Biotherapy include Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline and Eli Lilly, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Biotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Biotherapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Biotherapy Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Vaccines
Erythropoietin
Colony Stimulating Factors
Interleukins and Interferons
Global Cancer Biotherapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Biotherapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Pharmaceutical and Biotechnology Companies
Others
Global Cancer Biotherapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Biotherapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Biotherapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Biotherapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Bristol-Myers Squibb
Celgene
GlaxoSmithKline
Eli Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Biotherapy, market overview.
Chapter 2: Global Cancer Biotherapy market size in revenue.
Chapter 3: Detailed analysis of Cancer Biotherapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Biotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Biotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Biotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Biotherapy Overall Market Size
2.1 Global Cancer Biotherapy Market Size: 2022 VS 2029
2.2 Global Cancer Biotherapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Biotherapy Players in Global Market
3.2 Top Global Cancer Biotherapy Companies Ranked by Revenue
3.3 Global Cancer Biotherapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Biotherapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Biotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Biotherapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Biotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Biotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Biotherapy Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Vaccines
4.1.4 Erythropoietin
4.1.5 Colony Stimulating Factors
4.1.6 Interleukins and Interferons
4.2 By Type - Global Cancer Biotherapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Biotherapy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Biotherapy Revenue, 2024-2029
4.2.3 By Type - Global Cancer Biotherapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Biotherapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Research and Academic Laboratories
5.1.5 Pharmaceutical and Biotechnology Companies
5.1.6 Others
5.2 By Application - Global Cancer Biotherapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Biotherapy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Biotherapy Revenue, 2024-2029
5.2.3 By Application - Global Cancer Biotherapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Biotherapy Market Size, 2022 & 2029
6.2 By Region - Global Cancer Biotherapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Biotherapy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Biotherapy Revenue, 2024-2029
6.2.3 By Region - Global Cancer Biotherapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Biotherapy Revenue, 2018-2029
6.3.2 US Cancer Biotherapy Market Size, 2018-2029
6.3.3 Canada Cancer Biotherapy Market Size, 2018-2029
6.3.4 Mexico Cancer Biotherapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Biotherapy Revenue, 2018-2029
6.4.2 Germany Cancer Biotherapy Market Size, 2018-2029
6.4.3 France Cancer Biotherapy Market Size, 2018-2029
6.4.4 U.K. Cancer Biotherapy Market Size, 2018-2029
6.4.5 Italy Cancer Biotherapy Market Size, 2018-2029
6.4.6 Russia Cancer Biotherapy Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Biotherapy Market Size, 2018-2029
6.4.8 Benelux Cancer Biotherapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Biotherapy Revenue, 2018-2029
6.5.2 China Cancer Biotherapy Market Size, 2018-2029
6.5.3 Japan Cancer Biotherapy Market Size, 2018-2029
6.5.4 South Korea Cancer Biotherapy Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Biotherapy Market Size, 2018-2029
6.5.6 India Cancer Biotherapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Biotherapy Revenue, 2018-2029
6.6.2 Brazil Cancer Biotherapy Market Size, 2018-2029
6.6.3 Argentina Cancer Biotherapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Biotherapy Revenue, 2018-2029
6.7.2 Turkey Cancer Biotherapy Market Size, 2018-2029
6.7.3 Israel Cancer Biotherapy Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Biotherapy Market Size, 2018-2029
6.7.5 UAE Cancer Biotherapy Market Size, 2018-2029
7 Cancer Biotherapy Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Cancer Biotherapy Major Product Offerings
7.1.4 Amgen Cancer Biotherapy Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Cancer Biotherapy Major Product Offerings
7.2.4 Bristol-Myers Squibb Cancer Biotherapy Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Key News & Latest Developments
7.3 Celgene
7.3.1 Celgene Company Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Cancer Biotherapy Major Product Offerings
7.3.4 Celgene Cancer Biotherapy Revenue in Global Market (2018-2023)
7.3.5 Celgene Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Cancer Biotherapy Major Product Offerings
7.4.4 GlaxoSmithKline Cancer Biotherapy Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Eli Lilly
7.5.1 Eli Lilly Company Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Cancer Biotherapy Major Product Offerings
7.5.4 Eli Lilly Cancer Biotherapy Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Biotherapy Market Opportunities & Trends in Global Market
Table 2. Cancer Biotherapy Market Drivers in Global Market
Table 3. Cancer Biotherapy Market Restraints in Global Market
Table 4. Key Players of Cancer Biotherapy in Global Market
Table 5. Top Cancer Biotherapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Biotherapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Biotherapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Biotherapy Product Type
Table 9. List of Global Tier 1 Cancer Biotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Biotherapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Biotherapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Biotherapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Biotherapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Biotherapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Biotherapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Biotherapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Biotherapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Biotherapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Biotherapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Biotherapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Biotherapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Biotherapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Biotherapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Biotherapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Biotherapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Biotherapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Biotherapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Biotherapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Biotherapy Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Cancer Biotherapy Product Offerings
Table 32. Amgen Cancer Biotherapy Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. Bristol-Myers Squibb Company Summary
Table 35. Bristol-Myers Squibb Cancer Biotherapy Product Offerings
Table 36. Bristol-Myers Squibb Cancer Biotherapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol-Myers Squibb Key News & Latest Developments
Table 38. Celgene Company Summary
Table 39. Celgene Cancer Biotherapy Product Offerings
Table 40. Celgene Cancer Biotherapy Revenue (US$, Mn) & (2018-2023)
Table 41. Celgene Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Cancer Biotherapy Product Offerings
Table 44. GlaxoSmithKline Cancer Biotherapy Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Eli Lilly Company Summary
Table 47. Eli Lilly Cancer Biotherapy Product Offerings
Table 48. Eli Lilly Cancer Biotherapy Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly Key News & Latest Developments
List of Figures
Figure 1. Cancer Biotherapy Segment by Type in 2022
Figure 2. Cancer Biotherapy Segment by Application in 2022
Figure 3. Global Cancer Biotherapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Biotherapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Biotherapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Biotherapy Revenue in 2022
Figure 8. By Type - Global Cancer Biotherapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Biotherapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Biotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Biotherapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Biotherapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Biotherapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Biotherapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Biotherapy Revenue Market Share, 2018-2029
Figure 16. US Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Biotherapy Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Biotherapy Revenue Market Share, 2018-2029
Figure 28. China Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Biotherapy Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Biotherapy Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Biotherapy Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Cancer Biotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol-Myers Squibb Cancer Biotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celgene Cancer Biotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Cancer Biotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly Cancer Biotherapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
